Lung Cancer Trial, Recruiting (NCT07045103)

Lung Cancer Trial, Recruiting NCT07045103 Sponsor: Invenio Imaging Inc. Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07045103 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient or their legal guardian is willing and able to understand, sign, and date the study consent form that has been approved by an Ethics committee.
The patient is 22 years of age or older.
The patient is scheduled for two standard lung procedures: one to examine lymph nodes in the chest area (using a scope and needle), and one to take a tissue sample from the outer part of the lung — and their doctor considers them to have a moderate to high chance of having lung cancer.
The patient is healthy enough to safely undergo these procedures.

Who may not be able to join:

People who are currently imprisoned.
People who, in the opinion of the lead researcher, may not be suitable for the study procedures for any reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07045103

Sponsor: Invenio Imaging Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT07045103

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient or their legal guardian is willing and able to understand, sign, and date the study consent form that has been approved by an Ethics committee.
The patient is 22 years of age or older.
The patient is scheduled for two standard lung procedures: one to examine lymph nodes in the chest area (using a scope and needle), and one to take a tissue sample from the outer part of the lung — and their doctor considers them to have a moderate to high chance of having lung cancer.
The patient is healthy enough to safely undergo these procedures.

Who may not be able to join:

People who are currently imprisoned.
People who, in the opinion of the lead researcher, may not be suitable for the study procedures for any reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Invenio Imaging Inc.

Registry

ClinicalTrials.gov

Start date

21 December 2023

Est. completion

1 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Peripheral TBBx and CBx Co-primary Endpoints; Peripheral Lung Transbronchial Fine Needle Aspiration Endpoint; Lymph Node Endobronchial Ultrasound Transbronchial Fine Needle Aspiration Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov